Substance Use Treatment and Access to Resources (STARS) Project
University of Oklahoma
242 participants
Dec 16, 2020
INTERVENTIONAL
Conditions
Summary
This study is evaluating a randomized clinical trial and a quasi-experimental observational study combined. Pregnant women with substance abuse issues are referred to the Substance Use Treatment and Recovery (STAR) prenatal clinic, and those who consent to participate in the study will be randomized to the STAR + maternal Attachment Biobehavioral Catchup (mABC) home visiting model or to the STAR only treatment group. Those who opt out of receiving prenatal care at STAR will be recruited as a control group for the QED portion. Those randomized to STAR + mABC will receive additional supports from a licensed therapist, including up to 12 home visits focused on substance exposed babies and positive parenting.
Eligibility
Inclusion Criteria3
- Pregnant woman with substance abuse issue occurring during pregnancy
- Eligible for services at the STAR prenatal clinic
- Speaks/comprehends English
Exclusion Criteria2
- Unable to read English at 8th grade comprehension level
- Those outside of Oklahoma City metropolitan area.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Mothers receive up to 12 home visits from a licensed therapist focused on attachment and positive parenting in substance exposed babies. This includes 1 prenatal home visit and up to 11 postnatal visits.
Participants receive prenatal care in the STAR clinic (a clinic specifically designed to support mothers with substance abuse who are at risk of losing their children to child welfare at birth).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04459000